Case Series of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression
Main Article Content
Abstract
Introduction: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of brain stimulation therapy and The United States Food and Drug Administration (FDA) approved the use of rTMS for the treatment of major depressive disorder (MDD) in 2008. Meta-analyses have shown that patients with treatment-resistant depression (TRD) showed clinically significant improvement after treatment with rTMS but studies on the efficacy of rTMS in special populations such as the elderly are still very limited. Case Series: This case series aimed to report the efficacy of rTMS on treatment-resistant depression in patients of diverse ages in Hospital Sentosa Kuching, Malaysia. Four patients with treatment-resistant depression, aged 17 to 73 years old, completed the course of rTMS. All patients received 20 sessions of rTMS, with 120% motor threshold, 10 Hz rTMS, 3000 pulses per session, and five times per week. The outcome of treatment was measured using The Montgomery–Åsberg Depression Rating Scale (MADRS) and responders were defined as having ≥ 50% reduction in score. Conclusion: Two patients responded to the treatment and two elderly patients did not respond to the rTMS treatment, but it was well tolerated by all patients. rTMS can be a promising treatment option for TRD and more research may be needed to determine the most effective treatment protocol.
Downloads
Article Details
References
Gutie´rrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-Gonza´lez N, Cervilla JA. Prevalence and correlates of major depressive disorder: A systematic review. Brazilian Journal of Psychiatry. 2020; 42(6):657–72. doi: 10.1590/1516-4446-2020-0650.
Malaysian Healthcare Performance Unit. Mental Healthcare Performance Report: Technical Report 2016, Putrajaya: Ministry of Health Malaysia; 2017.
Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. The Psychiatry Clinics of North America. 1996;19(2):179–200. doi: 10.1016/s0193-953x(05)70283-5
Voineskos D, Daskalakis ZJ, Blumberger DM. Management of treatment-resistant depression: Challenges and strategies. Neuropsychiatric Disease and Treatment. 2020;21(16):221–34. doi: 10.2147/NDT.S198774.
Mrazek DA, Hornberger JC, Altar CA, Degtiar I. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatric Services. 2014;65(8):977-87. doi: 10.1176/appi.ps.201300059.
Magnezi R, Aminov E, Shmuel D, Dreifuss M, Dannon P. Comparison between neurostimulation techniques repetitive transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: Patient preference and cost-effectiveness. Patient Prefer Adherence. 2016;10:1481–7. doi: 10.2147/PPA.S105654.
Health Quality Ontario. Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Ontario Health Technology Assessment Series. 2016;16(5):1–66.
MacMaster FP, Croarkin PE, Wilkes TC, McLellan Q, Langevin LM, Jaworska N, et al. Repetitive transcranial magnetic stimulation in youth with treatment resistant major depression. Frontiers in Psychiatry. 2019;10:170. doi: 10.3389/fpsyt.2019.00170.
Croarkin PE, Elmaadawi AZ, Aaronson ST, Schrodt Jr GR, Holbert RC, Verdoliva S, et al. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: A double-blind, randomized, sham-controlled trial. Neuropsychopharmacology. 2021;46(2):462-469.
doi: 10.1038/s41386-020-00829-y.
Somani A, Kar SK. Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: The evidence thus far. General Psychiatry. 2019:32:e100074. doi: 10.1136/gpsych-2019-100074.
Sabesan P, Lankappa S, Khalifa N, Krishnan V, Gandhi R, Palaniyappan L. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatry. 2015;5(2):170-81. doi: 10.5498/wjp.v5.i2.170.
Licht-Strunk E, van der Windt DA, van Marwijk HW, de Haan M, Beekman AT. The prognosis of depression in older patients in general practice and the community. A systematic review. Family Practice. 2007;24(2):168–80. doi: 10.1093/fampra/cml071.
Valiengo L, Maia A, Cotovio G, Gzordon PC, Brunoni AR, Forlenza OV, Oliveira-Maia AJ. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: Systematic review and meta-analysis. Journal of Gerontology: Medical Sciences. 2022;71(4):851-860. doi: 10.1093/gerona/glab235.
Herzog DP, Wagner S, Engelmann J, Treccani G, Dremuller N, Muller MB, et al. Early onset of depression and treatment outcome in patients with major depressive disorder. Journal of Psychiatric Research. 2021;139:150-158. doi: 10.1016/j.jpsychires.2021.05.048.
Chen J, Zhou C, Wu B, Wang Y, Li Q, Wei Y, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: A meta-analysis of randomised controlled trials. Psychiatry Research. 2013;210(3):1260–4. doi: 10.1016/j.psychres.2013.09.007.